pyrrolopyrimidine JAK inhibitors (Cinkate Pharm Tech)

N/A

Report date: 2025/03/20 15:10:15
NME

Base Information

Drug Namepyrrolopyrimidine JAK inhibitors (Cinkate Pharm Tech)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionJanus kinase inhibitors
TargetsJanus kinase
Therapy Area/IndicationsInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesMedical Technology Enterprise Consortium
China Registration ClassN/A

Develop Information

Active CompaniesMedical Technology Enterprise Consortium
Inactive CompaniesN/A
Active IndicationsInflammationAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A